Prevalence of metabolic syndrome among Fars ethnic women in North East of Iran

World Journal of Medical Sciences

Volumn 7, Issue 1, 2012, Pages 17-22

  Marjani, Abdoljalal ^a   Hezarkhani, Sharabe ^a   Shahini, Najme ^a  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fars ethnic women; Gorgan; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HUMAN; IRAN; METABOLIC SYNDROME X; PATIENT ASSESSMENT; PREDICTION; PREVALENCE; RISK FACTOR; WAIST CIRCUMFERENCE; WOMEN'S HEALTH;

EID: 84857144664     PISSN: 18173055     EISSN: 19904061     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Miranda, P.J., R.A. DeFronzo, R.M. Califf and J.R. Guyton, 2005. Metabolic syndrome: definition, pathophysiology and mechanisms. Am Heart J., 149: 33-45.
2. Kylin, E., 1923. Studien ueber das Hypertonie- Hyperglykamie-Hyperurikamiesyndrom. Zentrallblatt fuer Innere Medizin, 44: 105-27.
3. Isomaa, B., P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, et al., 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24: 683-9.
4. Reaven, G.M. and Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes, 37: 1595-607.
5. Alberti, K.G. and P.Z. Zimmet, 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet Med., 15: 539-53.
6. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III). JAMA, 2001. 285: 2486-97.
7. Cameron, A.J., J.E. Shaw and P.Z. Zimmet, 2004. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab. Clin. N. Am., 33: 351-75.
8. Gupta, A., R. Gupta, M. Sarna, S. Rastogi, V.P. Grupta and K. Kothari, 2003. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res. Clin. Pract, 61: 69-76.
9. Ford, E.S., W.H. Giles and W.H. Dietz, 2002. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA, 287: 356-9.
10. Balkau, B., M. Vernay, L. Mhamdi, M. Novak, D. Arondel, S. Vol, et al., 2003. The D.E.S.I.R Study Group. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab, 29: 526-32.
11. Ramachandran, A., C. Snehalatha, K. Satyavani, S. Sivasankariand and V. Vijay, 2003. Metabolic syndrome in urban Asian Indian Adults-a population study using modified ATP III criteria. Diabetes Res. Clin Pract, 60: 199-204.
12. Shepherd, J., S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimerand Mac, P.W. Farlane, et al, 1995. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med., 333: 1301-7.
13. Downs, J.R., M. Clearfield, S. Weis, E. Whitney, D.R. Shapiroand PA. Beerc, et al, 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/ TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA, 279: 1615-22.
14. Ballantyne, C.M., A.G. Olsson, T.J. Cook, M.F. Mercuri, TR. Pedersen and J. Kjekshus, 2001. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation, 104: 3046-51.
15. Meigs, J.B., 2000. "Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors," American Journal of Epidemiology, 10: 908-912.
16. World Health Organization. Prevention and Management of the Global Epidemic of Obesity. Report of the WHO Consultation on Obesity. WHO: Geneva, 1998 (Technical Report Series, No. 894).
17. Dalton, M., A.J. Cameron, P.Z. Zimmet, J.E. Shaw, D.D. Jolley, D.W. Dunstan and T.A. Welborn, 2003. AusDiab Steering Committee. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J. Intern Med., 254: 555-63.
18. Trevisan, M., J. Liu, F.B. Bahsas and A. Menotti, 1998. "Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group," American J. Epidemiol., 10: 958 966.
19. Kim, H.M., J. Park, S.Y. Ryue and J. Kim, 2007. The effect of menopause on the metabolic syndrome among Korean women. The Korean National Health and Nutrition Examination Survey, 2001. Diabetes Care, 30: 701-6.
20. Gu, D., K. Reynolds, X. Wu et al., 2005 "Prevalence of the metabolic syndrome and overweight among adults in China," The Lancet, 9468: 1398-1405.
21. Eshtiaghi, R., A. Esteghamati and M. Nakhjavani, 2010. Menopause is an independent predictor of metabolic syndrome in Iranian women. Matutritas, 65: 262-266.
22. Ainy, E., P. Mirmiran, S. Zahedi Asl and F. Azizi, 2007. Prevalence of metabolic syndrome during menopausal transition Tehranian women. Tehran Lipid and Glucose Study (TLGS). Matutritas, 58: 150-5.
23. Deibert, P., D. Konig, M.Z. Vitolins, U. Landmann, I. Frey, Zahradnik, et al., 2007. effect of weight loss intervention on anthropometric measures and metabolic risk factors in pre- versus postmenopausal women. Nutr. J., 6: 31.
24. Figueiredo Neto, J.A., E.D. Figueredo, E.D. Barbosa, F. Barbosa Fde, G.R. Costa and V.J. Nina et al., 2010. Metabolic syndrome and menopause: Cross- sectional study in Gynecology clinic. Arq. Bras. Cardiol, 95: 339-45.
25. Heidari, R., M. Sadeghi, M. Talaei, K. Rabiei, N. Mohammadifard and N. Sarrafzadegan, 2010. Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study. Diabetol Metab. Syndr, 2: 59.
26. Athyros, V.G., E.S. Ganotakis, M. Bathianaki, I. Monedas, I.A. Goudevenos, A.A. Papageorgiou, et al., 2005. MetS-Greece Collaborative Group. Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study. Hellenic J. Cardiol., 46(6): 380-386.
27. Cameron, A.J., J.E. Shaw and P.Z. Zimmet, 2004. The metabolic syndrome: prevalence in worldwide populations. Endocrinology and metabolism clinics of North America. Metabolic Syndrome: Part 1, 33: 351-376.
28. Heiss, G., I. Tamir, C.E. Davis, et al., 1980. "Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study," Circulation, 2: 302-315.
29. Onat, A., G. Surdum-Avci, M. Senocak, E. Ornek and Y. Gozukara, 1992 "Plasma lipids and their interrelationship in Turkish adults," Journal of Epidemiology and Community Health, 5: 470-476.
30. The Research Group ATS-RF2 of the Italian National Research Council, "Distribution of some risk factors for atherosclerosis in nine Italian population samples," American J. Epidemiol., 1981. 113: 338-346.
31. MacLean, D.R., A. Petrasovits, P.W. Connelly, M. Joffres, B. O'Connor and J.A. Little, 1999. "Plasma lipids and lipoprotein reference values and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group," Canadian J. Cardiol., 4: 434-444.
32. Mann, J.I., B. Lewis, J. Shepherd, et al., 1988. "Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence and detection in Britain," British Medical J., 6638: 1702-1706.
33. Sharifi, F., S.N. Mousavinasab, R. Soruri, M. Saeini and M. Dinmohammadi, 2008. "High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population," Metabolic Syndrome and Related Disorders, 3: 187-195.
34. Azizi, F., A. Esmaillzadeh and P. Mirmiran, 2004. "Obesity and cardiovascular disease risk factors in Tehran adults: a populationbased study," Eastern Mediterranean Health J., 6: 887-897.
35. De Koning, L., A.T. Merchant, J. Pogueand and S.S. Anand, 2007. Waist circumference and waist-to- hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur. Heart J., 28: 850-6.
36. Hu, G., J. Tuomilehto, K. Silventoinen, C. Sarti, S. Männistöand and P. Jousilahti, 2007. Body mass index, waist circumference and waisthip ratio on the risk of total and type-specific stroke. Arch Intern Med., 167: 1420-7.
37. Despres, J.P., I. Lemieuxand and D. Prud'homme, 2001. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ, 322: 716-720.
38. Lobo, R.A., 2008. Metabolic syndrome after menopause and the role of hormones. Maturitas, 60: 10-18.
39. WHO Global infobase, "Iran: Most recent national survey (s) for chronic, non-communicable diseases risk factors," https://apps.who.int/infobase/report. aspx.
40. Mirmiran, P., F. Mohammadi and F. Allahverdian and S. Azizi, 2001. "Measurement of total energy requirement in adults: prospective Tehran Lipid and Glucose Study, Pajouhandeh," Journal of Shahid Beheshti University of Medical Sci., 6: 157-166 (Persian).